Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-24 @ 11:56 PM
NCT ID:
NCT01180751
Eligibility Criteria:
Inclusion Criteria:
* Known or suspected primary or metastatic tumours
* A neurological presentation consistent with the list of indications
* 18 years of age or older of either sex
* Able to provide written informed consent
* Able to tolerate the physical and logistical requirements of completing a Positron Emission Tomography (PET)scan
* Karnofsky score \> 60
* Women who are nursing may be included in the study if they are able to discontinue breast feeding for 12 hours
Exclusion Criteria:
* Age \<18 years
* Pregnant women; if there is a possibility of pregnancy, bloodwork will be drawn to definitively establish pregnancy status
* Women who are unwilling or unable to discontinue breast feeding for 12 hours post 18F-Fluorodeoxyglucose(FDG) administration
* Subjects who are medically unstable
* Subjects unwilling to provide informed consent.
* Subjects who exceed the safe weight limit of the Positron Emission Tomography (PET) imaging bed or who cannot fit through the PET scanner bore
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01180751
Study Brief:
Protocol Section:
NCT01180751